BeiGene, Ltd. (ONC)
NGS · Common · CUSIP 07725L102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ONC and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
07725L102
Market Cap
Large Cap
IPO
2/2/2016 · $24.00/share
ADR Ratio
1:13
Previous Symbol
BGNE
Business: BeiGene, Ltd. is a commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. BeiGene is working to create combination solutions aimed to have both a meaningful and a lasting impact on cancer patients.

Company Contact

CEO
John V. Oyler
CFO
Julia Wang
Investor Relations
857-302-5189 · ir@beonemed.com
SEC EDGAR Filings
View filings »